These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11819161)

  • 1. Body weight gain after administration of antipsychotic drugs.
    Baptista T; Lacruz A; De Mendoza D; Mendoza JM; Silvera R; Angeles F; Mendoza MT; Hernandez L
    Pharmacopsychiatry; 2002 Jan; 35(1):36. PubMed ID: 11819161
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
    Kostulski A; Wyszogrodzka-Kucharska A; Rabe-Jabłońska J
    Przegl Lek; 2005; 62(9):938-43. PubMed ID: 16541734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic connections between glucose/lipid disturbances and weight gain induced by antipsychotic drugs.
    Dwyer DS; Donohoe D; Lu XH; Aamodt EJ
    Int Rev Neurobiol; 2005; 65():211-47. PubMed ID: 16140058
    [No Abstract]   [Full Text] [Related]  

  • 4. The implications of weight changes with antipsychotic treatment.
    Sussman N
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antipsychotic agents and weight gain].
    Raaska K
    Duodecim; 2002; 118(2):157-62. PubMed ID: 12229110
    [No Abstract]   [Full Text] [Related]  

  • 6. Weight change with atypical antipsychotics in the treatment of schizophrenia.
    Haddad P
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):16-27. PubMed ID: 16280334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Weight increase as adverse effect of drugs].
    Spigset O
    Tidsskr Nor Laegeforen; 2000 Oct; 120(25):3044-5. PubMed ID: 11109394
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of weight gain induced by antipsychotic drugs.
    Baptista T
    J Clin Psychiatry; 2002 Mar; 63(3):245-6. PubMed ID: 11926725
    [No Abstract]   [Full Text] [Related]  

  • 9. No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.
    Zhang ZJ; Yao ZJ; Zhang XB; Chen JF; Sun J; Yao H; Hou G; Zhang XB
    Acta Pharmacol Sin; 2003 Mar; 24(3):235-40. PubMed ID: 12617772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
    Rege S
    Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exercising caution in choice of psychotropic drugs. Avoid drug-induced weight gain].
    MMW Fortschr Med; 2002 May; Suppl 2():89. PubMed ID: 12070872
    [No Abstract]   [Full Text] [Related]  

  • 12. Weight gain and first-generation antipsychotics: experience from a developing country.
    Yoon CK
    J Clin Psychopharmacol; 2008 Oct; 28(5):574-6. PubMed ID: 18794660
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlations between weight changes and lipid profile changes in schizophrenic patients after antipsychotics therapy.
    Huang TL; Lu CY
    Chang Gung Med J; 2007; 30(1):26-32. PubMed ID: 17477026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics.
    Reynolds GP; Hill MJ; Kirk SL
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):15-8. PubMed ID: 16785265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
    Popp J; Leucht S; Heres S; Steimer W
    Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antipsychotics and weight gain.
    Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):46-58. PubMed ID: 19667655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. -759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment.
    Ryu S; Cho EY; Park T; Oh S; Jang WS; Kim SK; Lee D; Hong KS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):673-7. PubMed ID: 17275977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T; Kin NM; Beaulieu S; de Baptista EA
    Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone-associated steatohepatitis and excessive weight-gain.
    Holtmann M; Kopf D; Mayer M; Bechtinger E; Schmidt MH
    Pharmacopsychiatry; 2003 Sep; 36(5):206-7. PubMed ID: 14571356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between antipsychotic-induced elevation of liver enzymes and weight gain: a prospective study.
    Rettenbacher MA; Baumgartner S; Eder-Ischia U; Edlinger M; Graziadei I; Hofer A; Huber R; Hummer M; Kemmler G; Weiss E; Fleischhacker WW
    J Clin Psychopharmacol; 2006 Oct; 26(5):500-3. PubMed ID: 16974192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.